Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Michela
Michela Becchi, Columbia, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20110173155 | DATA AWARE SCHEDULING ON HETEROGENEOUS PLATFORMS - Systems and method for data-aware scheduling of applications on a heterogeneous platform having at least one central processing unit (CPU) and at least one accelerator. Such systems and methods include a function call handling module configured to intercept, analyze, and schedule library calls on a processing element. The function call handling module further includes a function call interception module configured to intercept function calls to predefined libraries, a function call analysis module configured to analyze argument size and location, and a function call redirection module configured to schedule library calls and data transfers. The systems and methods also use a memory unification module, configured to keep data coherent between memories associated with the at least one CPU and the at least one accelerator based on the output of the function call redirection module. | 07-14-2011 |
Michela Becchi, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110119467 | MASSIVELY PARALLEL, SMART MEMORY BASED ACCELERATOR - Systems and methods for massively parallel processing on an accelerator that includes a plurality of processing cores. Each processing core includes multiple processing chains configured to perform parallel computations, each of which includes a plurality of interconnected processing elements. The cores further include multiple of smart memory blocks configured to store and process data, each memory block accepting the output of one of the plurality of processing chains. The cores communicate with at least one off-chip memory bank. | 05-19-2011 |
Michela Bettati, San Secondo (parma) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100009987 | AMINOTHIAZOLE DERIVATIVES AS INHIBITORS OF MARK - Compounds of formula (I): inhibit microtubule affinity regulating kinase (MARK) and therefore find use in treatment of neurodegenerative diseases associated with hyperphosphorylation of tau. | 01-14-2010 |
Michela Legora, Appiano Gentile IT
| Patent application number | Description | Published |
|---|---|---|
| 20100062083 | DERMAL FILM-FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO SKIN - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, forming a dermal film after application onto the skin, useful for delivery of actives onto the skin surface and in the stratum corneum. | 03-11-2010 |
Michela Morbin, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110010785 | PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES - The patent refers to a screening method carried out on biological material isolated from human and/or animal organisms for determining the risk of human and/or animal pathologies expressing an anomalous deposition of β-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, based on the investigation of the punctiform mutation Ala>Val in position 2 of the β-protein (corresponding to the Ala673Val mutation precursor of the β-protein containing 770 amino acids) in homozygosis or in heterozygosis. The patent provides for the possibility of: ( | 01-13-2011 |
Michela Noseda, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110110897 | Adult Human Cardiac-Derived Progenitor Cells - The present invention is based, in part, on the discovery that cardiac progenitor cells are present in and can be isolated from adult human heart. Accordingly, a cell of the present invention comprises a human adult cardiac-derived progenitor cell capable of differentiating into a cardiac myocyte where said cell is isolated according to the expression of specific biomarkers, identified elsewhere herein. The present invention also includes methods of use of an adult cardiac-derived progenitor cell in the treatment of heart disease. | 05-12-2011 |
Michela Petronio, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110293809 | Process for the Production of Biscuits Having Improved Organoleptic Properties - A process is described for the production of biscuits, characterised in that it comprises the steps of: mixing the ingredients of a biscuit dough, forming the biscuit dough to form semi-finished products, baking the semi-finished products formed from the dough, thus obtaining the biscuits, cooling the biscuits obtained and packaging of the biscuits; wherein the step of baking the semi-finished products comprises a step of exposure thereof to a hot gas consisting of hot air and superheated steam, blown directly on the semi-finished products by means of an impingement system; a description is also given of a biscuit comprising, in weight per total weight, a dietary fibre content comprised between 1 and 25%, a lipids content comprised between 4 and 23% and a simple sugars content comprised between 8 and 26%. | 12-01-2011 |
Michela Rampazzo, Saonara (padova) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100081368 | MOBILE LAMINAR FLOW HOOD FOR USE IN PODIATRY - A mobile laminar flow hood specifically devised for use in podiatry and a podiatric apparatus to which such hood is associated are described. The hood is adapted to generate a laminar flow of sterile air. In particular, an apparatus comprising a system for the generation and treatment of a laminar air flow in a intervention zone is described, together with means to support the system for the generation and treatment of a laminar air flow. The system comprises a blowing hood adapted to generate a laminar flow of sterile air towards said intervention zone, and a suctioning hood adapted to suck the laminar flow of sterile air from the intervention zone. | 04-01-2010 |
Michela Silacci-Melkko, Zurich CH
| Patent application number | Description | Published |
|---|---|---|
| 20110064751 | TARGETED IMMUNOCONJUGATES - The present invention relates to immunoconjugates. In particular embodiments, the present invention relates to immunoconjugates comprising at least one single-chain effector moiety and two or more antigen binding moieties. In addition, the present invention relates to nucleic acid molecules encoding such immunoconjugates, vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the immunoconjugates of the invention, and to methods of using these immunoconjugates in the treatment of disease. | 03-17-2011 |
Michela Tumiatti, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110223672 | INTEGRATED METHODS FOR CORROSIVITY, AGEING AND FINGERPRINTING DETERMINATION, AS WELL AS DIAGNOSIS, DECONTAMINATION, DEPOLARISATION AND DETOXIFICATION OF OILS - The methods of the invention are aimed toward the determination of corrosivity, ageing, fingerprinting and contaminants, as well as the functional diagnosis, decontamination, depolarisation and detoxification of oils and technical fluids, such as mineral insulating, natural and/or synthetic esters, lubricants, hydraulic fluids, diathermic fluids and technical fluids in general, used in apparatuses and equipment, such as electric transformers, reactors, bushings, switches and turbines, for the generation, transmission, distribution and use of power. | 09-15-2011 |
Michela Visintin, Trieste IT
| Patent application number | Description | Published |
|---|---|---|
| 20090317822 | SELECTION OF INTRACELLULAR IMMUNOGLOBULINS - A general immunoglobulin-target assay system is provided, in which a positive outcome (the generation of a signal) depends only on the intracellular interaction of immunoglobulin with target. This can be accomplished for many immunoglobulins expressed in yeast and/or in mammalian cells and allows the selection of immunoglobulins which are capable of functioning in an intracellular environment. | 12-24-2009 |